<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Transforming growth factor-beta 1 (TGF-beta 1), suggested in some studies to suppress astrocyte and neutrophil function, has also reduced ischaemic brain injury when administered immediately prior to clot embolization in models of <z:hpo ids='HP_0001727'>thromboembolic stroke</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The effect of TGF-beta 1 as a post-treatment paradigm was investigated in a rabbit model of <z:hpo ids='HP_0001727'>thromboembolic stroke</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Following clot embolization, regional cerebral blood flow fell to &lt; 10 cc 100 g-1 min-1 in <z:hpo ids='HP_0000001'>all</z:hpo> animals </plain></SENT>
<SENT sid="3" pm="."><plain>TGF-beta 1 (10 micrograms) or vehicle (n = 5 each group) was infused via the contralateral carotid artery </plain></SENT>
<SENT sid="4" pm="."><plain>TGF-beta 1 administration resulted in a rapid and selective reduction in the peripheral neutrophil count as compared to a significant (p &lt; 0.05) increase in control values (2336 +/- 817 vs 4320 +/- 928 neutrophils mm3, mean +/- <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SEM</z:e>) </plain></SENT>
<SENT sid="5" pm="."><plain>Neutrophil aggregation was increased within 30 min of TGF-beta 1 infusion when compared to control (2.07 +/- 0.70 vs 1.09 +/- 0.17 ohms, p &lt; 0.05); neutrophil chemiluminescence, an index of the oxygen respiratory burst was not significantly affected by TGF-beta 1 administration </plain></SENT>
<SENT sid="6" pm="."><plain>No difference in platelet counts or aggregation was noted </plain></SENT>
<SENT sid="7" pm="."><plain>There was no significant difference between the two groups regarding brain <z:mpath ids='MPATH_124'>infarct</z:mpath> size (47.5 +/- 10.9 vs 56.5 +/- 10.4, n = 4, TGF-beta vs control, mean +/- <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SEM</z:e>), intracranial pressure, or brain excitatory amino acid levels (<z:chebi fb="0" ids="29995">aspartate</z:chebi> and <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi>) within ischaemic regions.(ABSTRACT TRUNCATED AT 250 WORDS) </plain></SENT>
</text></document>